Search

Search Results
Results 101 - 110 of 127 for chronic pain syndrome
  • Hysone
    Drug - 28 Nov 2021
    Consumer Medicine Information (CMI) about Hysone intended for persons living in Australia.
  • Risperdal Tablets and Solution
    Drug - 27 Aug 2021
    Consumer Medicine Information (CMI) about Risperdal Tablets and Solution (Risperidone) intended for persons living in Australia.
  • Actiq
    Drug - 12 Aug 2021
    Consumer Medicine Information (CMI) about Actiq (fentanyl citrate) intended for persons living in Australia.
  • Loette (New Formulation)
    Drug - 16 Nov 2020
    Consumer Medicine Information (CMI) about Loette (New Formulation) (Levonorgestrel and Ethinylestradiol Tablets) intended for persons living in Australia.
  • Fluanxol
    Drug - 7 Oct 2020
    Consumer Medicine Information (CMI) about Fluanxol (Flupentixol decanoate) intended for persons living in Australia.
  • Norinyl-1
    Drug - 16 Mar 2020
    Consumer Medicine Information (CMI) about Norinyl-1 (Mestranol and Norethisterone) intended for persons living in Australia.
  • Modavigil
    Drug - 27 Feb 2020
    Consumer Medicine Information (CMI) about Modavigil (Modafinil) intended for persons living in Australia.
  • Thioprine 50
    Drug - 12 Feb 2020
    Consumer Medicine Information (CMI) about Thioprine 50 (azathioprine film-coated tablets) intended for persons living in Australia.
  • Loette
    Drug - 13 Dec 2019
    Consumer Medicine Information (CMI) about Loette (Levonorgestrel and Ethinylestradiol Tablets) intended for persons living in Australia.
  • Monofeme
    Drug - 12 Dec 2019
    Consumer Medicine Information (CMI) about Monofeme (Levonorgestrel and Ethinylestradiol Tablets) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback